Skip to content
Other

Effect of exchange rate changes on cash, cash equivalents and restricted cash

GE HealthCare Technologies Effect of exchange rate changes on cash, cash equivalents and restricted cash decreased by 164.9% to -$37M in Q1 2026 compared to the prior quarter. Year-over-year, this metric declined by 237.0%, from $27M to -$37M.

Analysis

StatementIncome Statement
SectionOther
First reportedQ1 2022
Last reportedQ1 2026Apr 29, 2026
Metric ID: other_effect_of_exchange_rate_on_cash_cash_equivalents_r_71d71e

Historical Data

11 periods
 Q1 '22Q2 '22Q3 '22Q1 '23Q2 '23Q3 '23Q1 '24Q2 '24Q1 '25Q2 '25Q1 '26
Value-$3M-$12M-$25M$8M-$11M-$31M-$19M-$22M$27M$57M-$37M
QoQ Change-300.0%-108.3%+132.0%-237.5%-181.8%+38.7%-15.8%+222.7%+111.1%-164.9%
YoY Change+366.7%+8.3%-24.0%-337.5%-100.0%+242.1%+359.1%-237.0%
Range-$37M$57M
CAGR+173.2%
Avg YoY Growth+34.7%
Median YoY Growth-7.8%

Effect of exchange rate changes on cash, cash equivalents and restricted cash at Other Companies

Frequently Asked Questions

What is GE HealthCare Technologies's effect of exchange rate changes on cash, cash equivalents and restricted cash?
GE HealthCare Technologies (GEHC) reported effect of exchange rate changes on cash, cash equivalents and restricted cash of -$37M in Q1 2026.
How has GE HealthCare Technologies's effect of exchange rate changes on cash, cash equivalents and restricted cash changed year-over-year?
GE HealthCare Technologies's effect of exchange rate changes on cash, cash equivalents and restricted cash decreased by 237.0% year-over-year, from $27M to -$37M.